Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.
about
PBPC mobilization with paclitaxel, ifosfamide, and G-CSF with or without amifostine: results of a prospective randomized trial.Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation.High-dose therapy with stem cell rescue for pediatric solid tumors: rationale and results.Therapeutic options in the treatment of multiple myeloma: pharmacoeconomic and quality-of-life considerations.Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral BloodLung cancer immunotherapy.Stem cell mobilization and collection for induction of mixed chimerism and renal allograft tolerance in cynomolgus monkeys.Clinical practice and future needs in recombinant human granulocyte colony-stimulating factor treatment: a review of randomized trials in clinical haemato-oncology.High-dose chemotherapy in adult patients with germ cell tumors.High-dose chemotherapy and stem cell transplantation for advanced testicular cancerMyeloid growth factors in oncology.Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation.A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.Prospective noninterventional study on peripheral blood stem cell mobilization in patients with relapsed lymphomas.High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation.Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells.Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors.Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftment.Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy?Rapid prediction of stem cell mobilization using volume and conductivity data from automated hematology analyzers.Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma.Does mobilization for autologous stem cell transplantation damage stromal layer formation?Inverse relationship between patient peripheral blood CD34+ cell counts and collection efficiency for CD34+ cells in two automated leukapheresis systems.High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany.A survey of blood utilization in children and adolescents in a German university hospital.Progenitor content of autologous grafts: mobilized bone marrow vs mobilized bloodHigh-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose
P2860
Q32137542-A93191CD-9FA8-4CE3-994A-FA8A91DC7838Q33333334-BA16ABBD-C92D-43E3-9F18-AF0A4793DC6DQ33788214-EF39EF05-5007-449B-839F-F113004EC300Q33809965-F823FD3A-CDD3-49A7-80C8-E5F147DCEC76Q33889604-E9A0B9BA-E6B8-4AB5-8536-982CCF14A3DCQ34146503-275ECDB2-05EA-437F-AF57-09A436C96B6AQ34185662-AEB5C110-24EE-4473-9684-136534A3A3C0Q34274265-5E54BD3C-6D3A-475D-931B-4958E9501927Q35071101-154FAEB1-4233-4F53-97E0-57544FEA9467Q35660641-7F282EEE-2125-458A-86F6-4279A6012D11Q36181140-B777F447-FD22-4B06-A818-5048FF6E3C21Q36292402-563FF7A7-1ED0-471C-97EF-479B53185EFDQ36445393-90D247CC-74D3-44EC-89E3-E56DB8C07953Q37390291-5577853C-EE43-44BF-B0AB-DD200AB8A676Q37875412-13EC7C12-0D6F-4A7B-B2BE-CBE865150C25Q38012658-3C6C7248-6600-4E95-A603-6D5E4DAFFD1FQ38666300-BE3709E1-CA8C-4825-9C12-8234E7CF27FAQ38951104-962B8A9C-AFA8-4647-8F93-537DA9B73593Q38966419-D1145E8C-0934-4CCE-9DBF-E89D7E181792Q40301448-C9EBD9BD-79DC-4B78-8D61-4C97EBBE9101Q40536250-C85054A3-6291-45AA-AFCD-0D38B20CBBA5Q44180625-27EA19C9-87C8-478D-80D2-25A6B5266010Q44197097-F61B6264-E65A-488F-8691-D789DFCE6805Q44793748-4A5E52B4-0751-43C9-AEB7-D2D61D178CAFQ45735258-D07ADDC0-17F8-4EF8-A38C-D6E3C9E4CE9DQ47325720-3D4A6793-436B-469B-AC71-4FFFBCB5E731Q47914097-B2D4F617-06D4-4007-8563-D61F783E2C6FQ51759891-297C68E4-23E7-4E49-93EE-6F6760CDB543Q52962706-014D482D-38F7-4447-853A-1D710ADE5B8DQ52975253-8C5076CB-8F68-4CEA-8DA3-66C3C8AFD10CQ53350706-C0642B44-6B0E-4BDF-8EF4-8583E8A953BCQ56777972-61C4F35B-4740-4E43-90A5-DDEB52DA58F1Q57218754-C8A6C9D3-D100-4AD3-8018-4CE2E79A03CA
P2860
Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Hematopoietic rescue after hig ...... rrow: a randomized comparison.
@ast
Hematopoietic rescue after hig ...... rrow: a randomized comparison.
@en
type
label
Hematopoietic rescue after hig ...... rrow: a randomized comparison.
@ast
Hematopoietic rescue after hig ...... rrow: a randomized comparison.
@en
prefLabel
Hematopoietic rescue after hig ...... rrow: a randomized comparison.
@ast
Hematopoietic rescue after hig ...... rrow: a randomized comparison.
@en
P2093
P1476
Hematopoietic rescue after hig ...... rrow: a randomized comparison.
@en
P2093
I Schwaner
I Strohscheer
N Schwella
P304
P356
10.1200/JCO.1995.13.6.1328
P407
P577
1995-06-01T00:00:00Z